Humaid Al Shamsi Recognized Among The 100 Most Influential CEOs in Oncology in 2025

Humaid Al Shamsi Recognized Among The 100 Most Influential CEOs in Oncology in 2025

Prof. Humaid Al  Shamsi is Founder and Director of the Medical Oncology Service at Burjeel Medical City, where he has been instrumental in advancing comprehensive cancer care in the United Arab Emirates. He holds board certification in medical oncology and internal medicine from the United States, Canada and the United Kingdom, making him an internationally board-certified gastrointestinal oncologist in UAE. His clinical practice encompasses a broad range of solid tumours, and he helped establish integrated palliative care services as part of multidisciplinary treatment delivery. Al Shamsi was the inaugural graduate of the Sheikh Khalifa Bin Zayed program for outstanding UAE physicians and has advised health authorities on national cancer control efforts, reflecting his commitment to elevating oncology standards in the region.

Al Shamsi also serves as President of the Emirates Oncology Society and Adjunct Clinical Professor of Oncology at the University of Sharjah, supporting professional training, guideline development and public health initiatives. Under his leadership, the Burjeel Cancer Institute network — serving thousands of patients annually across multiple Emirates — has expanded access to advanced diagnostics and treatments, including targeted therapies, immunotherapy, stereotactic radiosurgery and bone marrow transplantation. He has actively promoted cancer awareness and early detection through media engagement and community outreach, reinforcing efforts to improve outcomes and reduce stigma around cancer care in the UAE.

The 100 CEOs featured here reflect the diversity and complexity of modern oncology leadership. In 2025, some lead the world’s largest cancer institutions; others guide specialized societies or emerging innovators. What unites them is responsibility: for millions of patients, for the integrity of science, and for the future direction of cancer care globally.

This list is not a celebration of power, but a recognition of stewardship, accountability, and impact – and of the leaders whose choices continue to shape the fight against cancer. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.

See the full list of The 100 Most Influential CEOs in Oncology in 2025, and stay tuned for other special category nominations.

100 Most Influential CEOs